Actinium Pharmaceuticals reported $31K in Ordinary Share Capital for its fiscal quarter ending in March of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Actinium Pharmaceuticals USD 31K 0 Mar/2025
Amgen USD 539M 1000K Dec/2025
Bioline Rx USD 62.57M 24.47M Mar/2025
Capricor Therapeutics USD 46K 0 Mar/2025
Pfizer USD 5.69B 1000K Sep/2025